FDA Letter NEXUS PHARMS ANDA 214727

Letter

ANDA 214727

NEXUS PHARMS

Application #214727

Documents

Letter2021-04-13

Application Sponsors

ANDA 214727NEXUS PHARMS
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.